← All trials
NCT00572975
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2006
- Primary completion
- Mar 31, 2008
- Completion date
- Mar 31, 2008
- First posted
- Dec 13, 2007
- Last posted
- Sep 30, 2008
- Enrollment
- 9
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PennsylvaniaLead sponsor
- University of PennsylvaniaOverall official - principal investigator
- SolvayCollaborator
- Children's Hospital of PhiladelphiaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.